Rural Illinois Lung Cancer Screening Initiative
Part of paid clinical trials in Springfield, Illinois.
- Sponsor
- Southern Illinois University
- Study ID
- NCT06084078
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or telehealth visit. Computed tomography screening will be performed at an approved center closer to the individuals place of living and results will be discussed during follow-up in-person visit or telehealth visit.
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- Apr 2025
- Primary completion
- Aug 31, 2029
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Telehealth cohortIndividuals who opt to do the screening using telehealth. Telehealth using video assisted techniques or using telephone.
- Arm: In-person cohortIndividuals who are willing to travel to the hospital for in-person screening and follow-up
Primary Outcome Measure
Screening rate [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Sowmy Thuppal, MD PhD217-545-2320
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sowmy Thuppal | Springfield | Illinois | 62704 |
Find similar trials in Springfield, IL
By condition
By specialty
By research site
Related Studies
- A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung CancerPHASE3 · Not Yet Recruiting · Cell>Point LLC · Decatur, Illinois
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung CancerPHASE2/PHASE3 · Recruiting · Canadian Cancer Trials Group · Chicago, Illinois
- Prolonged Air Leak (PAL) Autologous Blood Patch Intervention TrialEnrolling By Invitation · Rush University Medical Center · Chicago, Illinois